Year |
Citation |
Score |
2011 |
Karunakaran S, Ramachandran S, Coothankandaswamy V, Elangovan S, Babu E, Periyasamy-Thandavan S, Gurav A, Gnanaprakasam JP, Singh N, Schoenlein PV, Prasad PD, Thangaraju M, Ganapathy V. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. The Journal of Biological Chemistry. 286: 31830-8. PMID 21771784 DOI: 10.1074/Jbc.M111.229518 |
0.589 |
|
2011 |
Ganapathy V, Karunakaran S, Ramachandran S, Babu E, Elangovan S, Periaswamy-Thandavan S, Schoenlein PV, Gurav A, Singh N, Prasad PD, Thangaraju M. Abstract 4459: a-Methyltryptophan (a-MT) inhibits estrogen receptor (ER)-positive breast cancer growth through blockade of SLC6A14 Cancer Research. 71: 4459-4459. DOI: 10.1158/1538-7445.Am2011-4459 |
0.558 |
|
2010 |
Karunakaran S, Schoenlein PV, Thangaraju M, Prasad PD, Ganapathy V. Abstract 4838: Alpha-methyltryptophan, a blocker of the amino acid transporter SLC6A14, induces autophagy and apoptosis in SLC6A14-positive breast cancer and colon cancer cell lines Cancer Research. 70: 4838-4838. DOI: 10.1158/1538-7445.Am10-4838 |
0.591 |
|
2009 |
Thangaraju M, Karunakaran SK, Itagaki S, Gopal E, Elangovan S, Prasad PD, Ganapathy V. Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate. Cancer. 115: 4655-66. PMID 19637353 DOI: 10.1002/Cncr.24532 |
0.404 |
|
2009 |
Ananth S, Karunakaran S, Martin PM, Nagineni CN, Hooks JJ, Smith SB, Prasad PD, Ganapathy V. Functional identification of a novel transport system for endogenous and synthetic opioid peptides in the rabbit conjunctival epithelial cell line CJVE. Pharmaceutical Research. 26: 1226-35. PMID 18781380 DOI: 10.1007/S11095-008-9709-X |
0.448 |
|
2008 |
Karunakaran S, Umapathy NS, Thangaraju M, Hatanaka T, Itagaki S, Munn DH, Prasad PD, Ganapathy V. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. The Biochemical Journal. 414: 343-55. PMID 18522536 DOI: 10.1042/Bj20080622 |
0.564 |
|
Show low-probability matches. |